Hannoch Marksheid
CEO
Claimed by owner Nurami Medical
Former names:
Nanofiber Technologies for Surgical Use
Nurami Medical
finance.walla.co.il
•
May 30, 2022
היישר מגונסון & גונסון: פיטר סטבינס מונה ליו"ר נוראמי מדיקל - וואלה! כסף
en.globes.co.il
•
Jan 27, 2022
Nurami seeks FDA, EU approval for soft tissue repair solution
bloomer.co.il
•
Oct 24, 2021
אלמדה ונצ'רס מודיעה על השלמת אבן דרך בחברת פורטפוליו בלומר
www.prnewswire.com
•
Nov 2, 2020
Nurami Medical Raises up to $6 Million Round in Series B Funding Led by Almeda Ventures
www.israel21c.org
•
Jul 16, 2019
Revolutionary patch keeps brain safe after cranial surgery
www.timesofisrael.com
•
Jan 1, 2017
Israeli biotechnology startup Nurami Medical raises NIS 2.5m
About
Nurami Medical is a medical-device company with proprietary nanofiber and sealant technology for soft-tissue repair. The company produces durable, highly flexible patches that seal undesired leakages and enhance tissue regeneration.
Nurami's first soft-tissue repair product, ArtiFascia, is a durable, biodegradable substitute patch for neurosurgeries that combines a porous fiber design with a smart sealant. The company is currently working on the next generation of ArtiFascia, which will be able to adhere to tissues without the need for sutures.
Nurami's first soft-tissue repair product, ArtiFascia, is a durable, biodegradable substitute patch for neurosurgeries that combines a porous fiber design with a smart sealant. The company is currently working on the next generation of ArtiFascia, which will be able to adhere to tissues without the need for sutures.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
ArtiFascia, ArtiFix, NovaFibreX
Geographic markets
United States, China, Europe
News
(6)
finance.walla.co.il
•
May 30, 2022
היישר מגונסון & גונסון: פיטר סטבינס מונה ליו"ר נוראמי מדיקל - וואלה! כסף
en.globes.co.il
•
Jan 27, 2022
Nurami seeks FDA, EU approval for soft tissue repair solution
bloomer.co.il
•
Oct 24, 2021
אלמדה ונצ'רס מודיעה על השלמת אבן דרך בחברת פורטפוליו בלומר
www.prnewswire.com
•
Nov 2, 2020
Nurami Medical Raises up to $6 Million Round in Series B Funding Led by Almeda Ventures
www.israel21c.org
•
Jul 16, 2019
Revolutionary patch keeps brain safe after cranial surgery
www.timesofisrael.com
•
Jan 1, 2017
Israeli biotechnology startup Nurami Medical raises NIS 2.5m
The Team
(3)
HM
Amir Bahar
Co-Founder, COO & Clinical Director
NN
Nora Nseir
Co-founder, Inventor, BOD, R&D Director
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Seed
$800K
Apr 2014
2 Investors
$800K
Seed
$650K
Dec 2016
2 Investors
$650K
A Round
$2M
Jul 2018
3 Investors
$2M
B Round
$6M
Nov 2020
2 Investors
$6M
Undisclosed Round
Undisclosed
Dec 2021
1 Investors
Undisclosed
Non-Equity Funding
Grant
$490K
Dec 2017
1 Grantors
$490K
Grant
$375K
Dec 2018
1 Grantors
$375K
Grant
$350K
Dec 2019
1 Grantors
$350K
Media gallery
(2)
Nurami Medical Technology 2017
Locations
Israel
Ha-Namal Street 36, Haifa, Israel
Locations
Israel
Ha-Namal Street 36, Haifa, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,